HIGHLIGHTS
- who: Na Liu from the University, China have published the paper: 131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer, in the Journal: (JOURNAL)
- what: The authors focused on how Caerin 1.1 and Caerin 1.9 inhibit the growth of NSCLC.
- how: The authors used chloramine-T to couple 131I with two high-affinity peptides (Caerin 1.1 and Caerin 1.9) and then analyzed the in_vivo and in_vitro effect of unlabeled Caerin 1.1 unlabeled Caerin 1.9 131I-labeled Caerin 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.